|
1) Fuster V, Corti R, Fayad ZA, et al. Integration of vascular biology and magnetic resonance imaging in the understanding of atherothrombosis and acute coronary syndromes. J Thromb Haemost. 2003; 1: 1410-21
|
|
|
|
2) Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest. 2005; 115: 3378-84
|
|
|
|
|
|
3) Lindemann S, Kramer B, Seizer P, et al. Platelets, inflammation and atherosclerosis. J Thromb Haemost. 2007; 5 Suppl 1: 203-11
|
|
|
|
|
|
4) Massberg S, Brand K, Gruner S, et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med. 2002; 196: 887-96
|
|
|
|
|
|
5) Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell. 1998; 94: 657-66
|
|
|
|
|
|
6) Kulkarni S, Dopheide SM, Yap CL, et al. A revised model of platelet aggregation. J Clin Invest. 2000; 105: 783-91
|
|
|
|
|
|
7) 冨山佳昭. 血栓形成のメカニズムup-to-date. Angiology Frontier. 2007; 6: 11-7
|
|
|
|
|
8) Hawrylowicz CM, Howells GL, Feldmann M. Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production. J Exp Med. 1991; 174: 785-90
|
|
|
|
|
|
9) Kaplanski G, Farnarier C, Kaplanski S, et al. Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism. Blood. 1994; 84: 4242-8
|
|
|
|
|
|
10) Gawaz M, Brand K, Dickfeld T, et al. Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis. Atherosclerosis. 2000; 148: 75-85
|
|
|
|
|
|
11) Lu B, Rutledge BJ, Gu L, et al. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med. 1998; 187: 601-8
|
|
|
|
|
|
12) Denis MM, Tolley ND, Bunting M, et al. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell. 2005; 122: 379-91
|
|
|
|
|
|
13) Schwertz H, Tolley ND, Foulks JM, et al. Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med. 2006; 203: 2433-40
|
|
|
|
|
|
14) Lindemann S, Tolley ND, Dixon DA, et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis. J Cell Biol. 2001; 154: 485-90
|
|
|
|
|
|
15) von Hundelshausen P, Weber KS, Huo Y, et al. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation. 2001; 103: 1772-7
|
|
|
|
|
|
16) Scheuerer B, Ernst M, Durrbaum-Landmann I, et al. The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. Blood. 2000; 95: 1158-66
|
|
|
|
|
|
17) Lindemann S, Kramer B, Daub K, et al. Molecular pathways used by platelets to initiate and accelerate atherogenesis. Curr Opin Lipidol. 2007; 18: 566-73
|
|
|
|
|
|
18) Mach F, Schonbeck U, Sukhova GK, et al. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature. 1998; 394: 200-3
|
|
|
|
|
|
19) Lutgens E, Gorelik L, Daemen MJ, et al. Requirement for CD154 in the progression of atherosclerosis. Nat Med. 1999; 5: 1313-6
|
|
|
|
|
|
20) Henn V, Slupsky JR, Grafe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature. 1998; 391: 591-4
|
|
|
|
|
|
21) Slupsky JR, Kalbas M, Willuweit A, et al. Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40. Thromb Haemost. 1998; 80: 1008-14
|
|
|
|
|